Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Court

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Genome Research|September 20, 2019
Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanismsFranck Court, Elisa Le Boiteux, Anne Fogli, et al.
Journal of Hematology & Oncology|January 11, 2014
Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levelsAmy Guillaumet-Adkins, Julia Richter, Maria D Odero, et al.
Nucleic Acids Research|September 25, 2015
Imprinting control regions (ICRs) are marked by mono-allelic bivalent chromatin when transcriptionally inactiveStéphanie Maupetit-Méhouas, Bertille Montibus, David Nury, et al.
Plos One|June 5, 2012
H19 antisense RNA can up-regulate Igf2 transcription by activation of a novel promoter in mouse myoblastsVan Giang Tran, Franck Court, Anne Duputié, et al.
Human Molecular Genetics|March 17, 2022
L1 chimeric transcripts are expressed in healthy brain and their deregulation in glioma follows that of their host locusMarie-Elisa Pinson, Franck Court, Aymeric Masson, et al.
Molecular Oncology|March 26, 2018
DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34<sup>+</sup> CD15<sup>-</sup> cells in early chronic-phase chronic myeloid leukemiaStéphanie Maupetit-Mehouas, Franck Court, Céline Bourgne, et al.
Cellular and Molecular Life Sciences : CMLS|May 15, 2020
TET3 controls the expression of the H3K27me3 demethylase Kdm6b during neural commitmentBertille Montibus, Jil Cercy, Tristan Bouschet, et al.
Carcinogenesis|January 1, 2016
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survivalAnne Fogli, Emmanuel Chautard, Catherine Vaurs-Barrière, et al.
Human Mutation|March 4, 2017
Maternal mutations of FOXF1 cause alveolar capillary dysplasia despite not being imprintedMiguel Alsina Casanova, Ana Monteagudo-Sánchez, Luciana Rodiguez Guerineau, et al.
Genome Research|October 6, 2018
High-salt-recovered sequences are associated with the active chromosomal compartment and with large ribonucleoprotein complexes including nuclear bodiesMarie-Odile Baudement, Axel Cournac, Franck Court, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Genome Research|September 20, 2019
Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanismsFranck Court, Elisa Le Boiteux, Anne Fogli, et al.
Journal of Hematology & Oncology|January 11, 2014
Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levelsAmy Guillaumet-Adkins, Julia Richter, Maria D Odero, et al.
Nucleic Acids Research|September 25, 2015
Imprinting control regions (ICRs) are marked by mono-allelic bivalent chromatin when transcriptionally inactiveStéphanie Maupetit-Méhouas, Bertille Montibus, David Nury, et al.
Plos One|June 5, 2012
H19 antisense RNA can up-regulate Igf2 transcription by activation of a novel promoter in mouse myoblastsVan Giang Tran, Franck Court, Anne Duputié, et al.
Human Molecular Genetics|March 17, 2022
L1 chimeric transcripts are expressed in healthy brain and their deregulation in glioma follows that of their host locusMarie-Elisa Pinson, Franck Court, Aymeric Masson, et al.
Molecular Oncology|March 26, 2018
DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34<sup>+</sup> CD15<sup>-</sup> cells in early chronic-phase chronic myeloid leukemiaStéphanie Maupetit-Mehouas, Franck Court, Céline Bourgne, et al.
Cellular and Molecular Life Sciences : CMLS|May 15, 2020
TET3 controls the expression of the H3K27me3 demethylase Kdm6b during neural commitmentBertille Montibus, Jil Cercy, Tristan Bouschet, et al.
Carcinogenesis|January 1, 2016
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survivalAnne Fogli, Emmanuel Chautard, Catherine Vaurs-Barrière, et al.
Human Mutation|March 4, 2017
Maternal mutations of FOXF1 cause alveolar capillary dysplasia despite not being imprintedMiguel Alsina Casanova, Ana Monteagudo-Sánchez, Luciana Rodiguez Guerineau, et al.
Genome Research|October 6, 2018
High-salt-recovered sequences are associated with the active chromosomal compartment and with large ribonucleoprotein complexes including nuclear bodiesMarie-Odile Baudement, Axel Cournac, Franck Court, et al.
Pageof 4